551 results on '"Garonzik-Wang, Jacqueline M"'
Search Results
2. Early national and center‐level changes to kidney transplantation in the United States during the COVID‐19 epidemic
3. Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
4. Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study
5. Anti‐spike antibody durability after SARS‐CoV‐2 vaccination in adolescent solid organ transplant recipients
6. Letter to the editor: Poor sensitivity of anti‐nucleocapsid antibody in detecting prior COVID‐19 in vaccinated solid organ transplant recipients
7. Ambient air pollution and posttransplant outcomes among kidney transplant recipients
8. Omicron Infections in Vaccinated Pediatric Solid Organ Transplant Recipients
9. Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses
10. 416.2: Early Clinical Complications Following HLA-Incompatible Living Donor Kidney Transplantation
11. 400.5: Outcomes After Declining a Donation After Cardiac Death (DCD) Liver for Transplant Candidates in the United States
12. 330.5: A Prediction Model for Antibody Response to Three Vaccines Against SARS-CoV-2 Among Solid Organ Transplant Recipients
13. 330.4: SARS-coV-2 Antibody Response to a Third Dose of Homologous mRNA Vaccination in Liver Transplant Recipients
14. 230.3: Antibody Response to a Third Dose of SARS-CoV-2 Vaccine in Heart and Lung Transplant Recipients
15. 230.6: Ad.26.COV2.S Versus BNT162b2 or mRNA-1273 as a Third Dose in Solid Organ Transplant Recipients Seronegative After 2-dose mRNA Vaccination
16. 210.5: Differential Immunogenicity of mRNA-1273 Versus BNT162b2 as a Third Vaccine Dose for Solid Organ Transplant Recipients Seronegative After Two BNT162b2 Doses.
17. Incidence and Severity of COVID-19 Among Vaccinated Solid Organ Transplant Recipients During the Omicron Wave
18. Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients
19. Quantifying infection risks in incompatible living donor kidney transplant recipients
20. Survival benefit of accepting kidneys from older donation after cardiac death donors
21. 6-mo Antibody Kinetics and Durability After 3 Doses of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
22. Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: A stochastic simulation and machine learning study
23. Effects of COVID-19 pandemic on pediatric kidney transplant in the United States
24. How do highly sensitized patients get kidney transplants in the United States? Trends over the last decade
25. Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma
26. Early impact of COVID-19 on transplant center practices and policies in the United States
27. Panel-reactive Antibody and the Association of Early Steroid Withdrawal With Kidney Transplant Outcomes
28. Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case Series
29. Characterizing the risk of human leukocyte antigen-incompatible living donor kidney transplantation in older recipients
30. Temporal trends and hospital costs associated with an endovascular-first approach for acute limb ischemia
31. Accelerating kidney allocation: Simultaneously expiring offers
32. Six-month Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients
33. Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
34. Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients
35. Mentorship for Research Success
36. Limited health literacy and adverse outcomes among kidney transplant candidates
37. Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor–recipient combination
38. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients
39. Trends in Heart and Lung Transplantation in the United States Across the COVID-19 Pandemic
40. Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension
41. Transplant of SARS-CoV-2–infected Living Donor Liver: Case Report
42. Living donor postnephrectomy kidney function and recipient graft loss: A dose-response relationship
43. Comprehensive quality initiative leads to immediate postoperative extubation following liver transplant
44. Liver Transplantation for Severe Alcoholic Hepatitis, Updated Lessons from the World’s Largest Series
45. Financial incentives versus standard of care to improve patient compliance with live kidney donor follow-up: protocol for a multi-center, parallel-group randomized controlled trial
46. Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients with Hepatitis C Virus
47. Omicron Infections in Vaccinated Pediatric Solid Organ Transplant Recipients.
48. PANEL REACTIVE ANTIBODY AND THE ASSOCIATION OF EARLY STEROID WITHDRAWAL WITH KIDNEY TRANSPLANT OUTCOMES
49. Kidney Dyads: Caregiver Burden and Relationship Strain Among Partners of Dialysis and Transplant Patients
50. Early Experiences With COVID-19 Testing in Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.